-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-03-05
The Chinese mainland reported no new locally transmitted COVID-19 cases on March 4, the National Health Commission said Friday.
-
Sinopharm chairman says vaccines can protect against COVID variants
2021-03-05
Early research shows that the inactivated COVID-19 vaccines produced by Sinopharm can provide protection against 10 mutated variants of SARS-CoV-2, including strains from the United Kingdom and South Africa, said Yu Qingming, Sinopharm's board chairman and a deputy to the National People's Congress.
-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-03-04
The Chinese mainland reported no new locally transmitted COVID-19 cases on Wednesday, the National Health Commission said on March 4.
-
Output of Sinopharm COVID-19 vaccines to top 1 bln doses in 2021
2021-03-04
China has put the inactivated COVID-19 vaccines developed by state-owned pharmaceutical firm Sinopharm into mass production and this year's output is expected to surpass 1 billion doses, Yu Qingming, chairman of Sinopharm Group, said on March 3.
-
Spokesperson: China always puts vaccine safety, efficacy first
2021-03-04
China always puts the safety and efficacy of COVID-19 vaccines first, a spokesperson for the annual session of the country's top political advisory body said on March 3.
-
Over 5 mln get COVID-19 vaccine in Beijing
2021-03-04
Over 5 million people in Beijing had received COVID-19 vaccines as of 2 pm on March 2, local authorities said.
